Biopharma Business

Tag "Colorado University School of Medicine"

Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer

    Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer

EGFR is a common genetic target in lung cancer, but not all EGFR mutations are created equal. Patients with a type of EGFR anomaly called an “EGFR exon 20 insertion”

Read Full Article

Upcoming Events

  • No upcoming events
AEC v1.0.4

The Magazine

New Subscriber





Subscribe Here



Advertisements